Literature DB >> 25368231

Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.

Kamel F Khazal1, Donald L Hill2, Clinton J Grubbs3.   

Abstract

The cancer-preventive activity of an extract of Withania somnifera (WS) roots was examined in female transgenic (MMTV/Neu) mice that received a diet containing the extract (750 mg/kg of diet) for 10 months. Mice in the treated group (n=35) had an average of 1.66 mammary carcinomas, and mice in the control group (n=33) had 2.48, showing a reduction of 33%. The average weights of the carcinomas were 2.36 g for mice in the treated group and 2.63 g for the controls, a difference of 10%. Labeling indices for Ki67 and proliferating cell nuclear antigen marker in mammary carcinomas of the treated group were 35% and 30% lower, respectively, than those of the corresponding control group. Expression of the chemokine was reduced by 50%. These results indicate that the root extract reduced the number of mammary carcinomas that developed and reduced the rate of cell division in the carcinomas. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Withania; chemoprevention; mammary cancer; mice

Mesh:

Substances:

Year:  2014        PMID: 25368231      PMCID: PMC4386658     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

1.  Breast Cancer in Developing Countries: Challenges for Multidisciplinary Care.

Authors:  Raimund Jakesz
Journal:  Breast Care (Basel)       Date:  2008-02-15       Impact factor: 2.860

Review 2.  Triple-negative breast cancer: epidemiological considerations and recommendations.

Authors:  P Boyle
Journal:  Ann Oncol       Date:  2012-08       Impact factor: 32.976

3.  Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma.

Authors:  L Davis; G Kuttan
Journal:  J Exp Clin Cancer Res       Date:  2000-06

4.  Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Adam I Marcus; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2013-11-30       Impact factor: 4.784

5.  Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Authors:  Yanke Yu; Adel Hamza; Tao Zhang; Mancang Gu; Peng Zou; Bryan Newman; Yanyan Li; A A Leslie Gunatilaka; Chang-Guo Zhan; Duxin Sun
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

6.  Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas.

Authors:  Kamel F Khazal; Temesgen Samuel; Donald L Hill; Clinton J Grubbs
Journal:  Anticancer Res       Date:  2013-04       Impact factor: 2.480

7.  Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.

Authors:  Silvia D Stan; Yan Zeng; Shivendra V Singh
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

Review 8.  Steroidal lactones from Withania somnifera, an ancient plant for novel medicine.

Authors:  Mohammad Hossein Mirjalili; Elisabeth Moyano; Mercedes Bonfill; Rosa M Cusido; Javier Palazón
Journal:  Molecules       Date:  2009-07-03       Impact factor: 4.411

9.  Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition.

Authors:  Zhen Yang; Anapatricia Garcia; Songli Xu; Doris R Powell; Paula M Vertino; Shivendra Singh; Adam I Marcus
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.

Authors:  Katarzyna Szarc vel Szic; Ken Op de Beeck; Dariusz Ratman; An Wouters; Ilse M Beck; Ken Declerck; Karen Heyninck; Erik Fransen; Marc Bracke; Karolien De Bosscher; Filip Lardon; Guy Van Camp; Wim Vanden Berghe
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  7 in total

Review 1.  Withania somnifera: From prevention to treatment of cancer.

Authors:  Dushani L Palliyaguru; Shivendra V Singh; Thomas W Kensler
Journal:  Mol Nutr Food Res       Date:  2016-01-29       Impact factor: 5.914

2.  Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis.

Authors:  Kamel F Khazal; Donald L Hill
Journal:  J Cancer Metastasis Treat       Date:  2015-07-15

3.  Natural product HTP screening for attenuation of cytokine-induced neutrophil chemo attractants (CINCs) and NO2- in LPS/IFNγ activated glioma cells.

Authors:  Elizabeth A Mazzio; David Bauer; Patricia Mendonca; Equar Taka; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2016-12-01       Impact factor: 3.478

Review 4.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

Review 5.  Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology.

Authors:  Rinku Dutta; Roukiah Khalil; Ryan Green; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

6.  The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.

Authors:  Lyndsey A Reich; Jessica A Moerland; Ana S Leal; Di Zhang; Sarah Carapellucci; Beth Lockwood; Peter W Jurutka; Pamela A Marshall; Carl E Wagner; Karen T Liby
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 7.  Natural Withanolides in the Treatment of Chronic Diseases.

Authors:  Peter T White; Chitra Subramanian; Hashim F Motiwala; Mark S Cohen
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.